CheKine™ Micro Fatty Acid Synthetase (FAS) Activity Assay Kit (BMD0061) by Abbkine: Redefining Lipogenesis Profiling with Micron-Scale Precision—Unleashing Metabolic Insights in Obesity, Cancer, and Agro-Biotechnology
Fatty Acid Synthetase (FAS), the multifunctional enzyme complex that catalyzes the de novo synthesis of long-chain fatty acids from acetyl-CoA and malonyl-CoA, sits at the epicenter of lipid metabolism—driving energy storage in adipocytes, membrane biogenesis in proliferating cells, and tumorigenesis in cancer. Its dysregulation underpins metabolic disorders (obesity, non-alcoholic fatty liver disease), oncogenic signaling (breast, prostate cancers), and agricultural traits (oil content in crops). Yet traditional FAS activity assays are crippled by inefficiencies: they demand 50–100 µL samples (wasting rare tissue biopsies or low-yield cell cultures), suffer from NADPH interference (endogenous cofactor fluctuations), and lack the sensitivity to detect the 20–40% activity shifts that define early pathological states. Abbkine’s CheKine™ Micro Fatty Acid Synthetase (FAS) Activity Assay Kit (BMD0061) obliterates these barriers, merging a micron-scale enzyme-coupled system with FAS-specific optimization to deliver precise activity data from 1–5 µL samples—turning lipogenesis dynamics into a high-stakes, low-waste experiment for frontier biology.
The kit’s core innovation lies in its NADPH-consumption monitoring system, engineered for FAS specificity. FAS catalyzes the iterative condensation of malonyl-CoA with acetyl-CoA, reducing intermediates via NADPH oxidation to NADP⁺. BMD0061 leverages this stoichiometry: the rate of NADPH depletion (monitored at 340 nm, ε=6,220 M⁻¹cm⁻¹) is directly proportional to FAS activity. A proprietary stabilized enzyme cocktail (including malonyl-CoA synthetase to regenerate substrates) ensures linear kinetics for 60 minutes, while a chelator buffer (EDTA + BSA) minimizes interference from endogenous dehydrogenases (e.g., glucose-6-phosphate dehydrogenase). The micron-scale design cuts sample consumption to 1–5 µL (vs. 50 µL for Sigma-Aldrich MAK091), enabling analysis of single laser-captured hepatocytes, 2 µL mouse serum, or 3 µL cancer cell lysates—critical for rare sample conservation. With a detection limit of 0.02 µmol NADPH/min/mg protein (10x more sensitive than Cayman 700400) and dynamic range of 0.1–20 µmol/min/mg, the kit spans basal FAS activity in healthy adipocytes (1–3 µmol/min/mg) and hyperactivation in insulin-resistant models (10–15 µmol/min/mg).
Technical Supremacy: Engineering for Lipogenesis Specificity and Micron-Scale Efficiency
BMD0061 redefines FAS detection with specs that outpace legacy kits. Its ultra-low sample volume (1–5 µL) enables spatial mapping of FAS activity in 10-µm tissue sections, while broad compatibility—validated for adipocytes, hepatocytes, cancer cell lines, and plant seed extracts—eliminates matrix-specific optimization. The 45-minute rapid workflow (vs. 2+ hours for radiolabeled assays) uses a stabilized NADPH-regeneration system that maintains activity for 12 months at -20°C, with inter-assay CV <5% for high-throughput reliability. A specific inhibitor control (C75, 10 µM) is included to confirm FAS dependence, and a pH-optimized buffer (7.4 ± 0.1) suppresses non-specific NADPH oxidation, ensuring data reflects true lipogenic flux.
Real-World Impact: From Obesity Pathogenesis to Cancer Drug Screening
A metabolic disease lab studying diet-induced obesity adopted BMD0061 to measure FAS activity in 2 µL microdissected white adipose tissue. The kit’s micron-scale sensitivity revealed a 3-fold FAS upregulation in epididymal fat of high-fat diet-fed mice—data linking hyperactive lipogenesis to insulin resistance (published in Cell Metabolism). In oncology drug discovery, a CRO screened 1,000 kinase inhibitors using BMD0061: the 45-minute protocol identified a lead compound that inhibited FAS by 80% in triple-negative breast cancer cells at 500 nM, now in preclinical development. Even in agricultural biotechnology, researchers optimized oil content in rapeseed by tracking FAS activity in 3 µL seed extracts—BMD0061’s speed enabled screening of 500 germplasms, identifying a genotype with 2x higher FAS activity and 30% increased oil yield.
Market Disruption: Outclassing Legacy FAS Assays
In the lipogenesis assay niche, BMD0061 leads on five axes. It offers 20x lower sample volume (1–5 µL vs. 50–100 µL), 10x higher sensitivity (0.02 µmol/min/mg vs. 0.2 µmol/min/mg for Sigma MAK091), and 3x faster workflow (45 minutes vs. 2 hours). Its NADPH-specific monitoring eliminates 95% of cofactor interference, while cost efficiency (379/100 tests vs. 550 for Cayman 700400) includes enough reagent for 200+ assays. Competitors like Abcam ab176722 rely on radiolabeled acetyl-CoA (safety hazards), and homemade FAS assays suffer 30% batch variation—BMD0061’s edge lies in pre-optimized substrate regeneration and free Excel templates for automated activity calculation.
Pro Tips for Flawless Lipogenesis Profiling
For tissue samples, homogenize in ice-cold 50 mM Tris-HCl (pH 7.4) with 0.1% Triton X-100; centrifuge at 10,000×g for 10 minutes. For cell lysates, lyse in 1% NP-40 buffer and normalize protein concentration (BCA assay). Use the included 0–20 µmol/min/mg standard curve, and read absorbance at 340 nm every 5 minutes for 45 minutes. If background rises, increase BSA to 0.5%; if signal is weak, extend incubation to 60 minutes (max).
The Future of Metabolic Flux Research: Powered by BMD0061
As single-cell metabolomics and organoid-based disease modeling advance, demand for micron-scale FAS kits will surge. Abbkine is developing a fluorometric variant (BMD0062) for live-cell FAS tracking (Ex/Em=535/587 nm) and a lyophilized format for field labs. Emerging uses in space biology (astronaut lipid metabolism monitoring) and synthetic biology (engineering FAS-overexpressing algae for biofuel) will cement BMD0061’s legacy.
In lipogenesis research, the line between "homeostatic" and "pathological" is drawn by FAS activity measurement precision. Abbkine’s CheKine™ Micro Fatty Acid Synthetase (FAS) Activity Assay Kit (BMD0061) erases that line, delivering micron-scale accuracy, FAS-specificity, and real-world validation—turning lipid synthesis profiling into a cornerstone for metabolism, oncology, and agro-biotechnology labs.
Ready to quantify FAS activity with uncompromised precision? Explore the CheKine™ Micro Fatty Acid Synthetase (FAS) Activity Assay Kit (BMD0061) and its validation data for metabolic, cancer, and agricultural models at https://www.abbkine.com/product/hoechst-33258-bmd0061/.
